🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

11+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 11 of 11 recruiting trials for “friedreich-ataxia

RecruitingNCT06628687

A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies

👨‍⚕️ Medical Director, Biogen📍 1 site📅 Started Oct 2026View details ↗
RecruitingNCT06865482

Clinical Course Of Disease In Participants With FA-CM

👨‍⚕️ Lexeo Clinical Trials, Lexeo Therapeutics📍 10 sites📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT06953583

A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)

👨‍⚕️ Medical Director, Biogen📍 34 sites📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT06874010

A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

🏥 Design Therapeutics, Inc.📍 3 sites📅 Started Jun 2025View details ↗
NARecruitingNCT06692296

Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia

👨‍⚕️ Gabriella Paparella, Medical Degree, Scientific Institute, IRCCS E. Medea, Department of Conegliano, Treviso, Italy.📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06623890

A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

👨‍⚕️ Medical Director, Biogen📍 14 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06054893

A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old

👨‍⚕️ Medical Director, Biogen📍 1 site📅 Started Jul 2024View details ↗
Phase 2RecruitingNCT06447025

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

👨‍⚕️ Larimar Therapeutics, Inc., Larimar Therapeutics, Inc.📍 8 sites📅 Started Jan 2024View details ↗
RecruitingNCT06016946

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

👨‍⚕️ David Lynch, MD, Children's Hospital of Philadelphia📍 34 sites📅 Started Jun 2023View details ↗
RecruitingNCT05874388

Characterisation of the Cognitive Profile of Patients Suffering From Friedreich's Ataxia

👨‍⚕️ Benoit Funalot, APHP📍 1 site📅 Started Jun 2023View details ↗
Phase 1RecruitingNCT05302271

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

👨‍⚕️ Ronald G Crystal, MD, Weill Medical College of Cornell University📍 1 site📅 Started Feb 2022View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →